X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (161) 161
humans (145) 145
female (114) 114
child (113) 113
male (112) 112
oncology (94) 94
child, preschool (84) 84
hematology (80) 80
adolescent (74) 74
article (65) 65
infant (64) 64
children (53) 53
treatment outcome (49) 49
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (48) 48
abridged index medicus (46) 46
precursor cell lymphoblastic leukemia-lymphoma - genetics (44) 44
cancer (41) 41
minimal residual disease (41) 41
acute lymphocytic leukemia (40) 40
therapy (40) 40
adult (38) 38
acute lymphoblastic leukemia (37) 37
pediatrics (37) 37
risk (37) 37
antineoplastic combined chemotherapy protocols - therapeutic use (36) 36
disease-free survival (36) 36
leukemia (36) 36
risk factors (35) 35
chemotherapy (33) 33
prognosis (32) 32
precursor cell lymphoblastic leukemia-lymphoma - mortality (28) 28
research (28) 28
childhood (26) 26
genetic aspects (25) 25
acute lymphatic leukemia (22) 22
young adult (22) 22
care and treatment (21) 21
health aspects (21) 21
antineoplastic combined chemotherapy protocols - adverse effects (20) 20
clinical trials and observations (20) 20
methotrexate - administration & dosage (20) 20
original reports (20) 20
expression (19) 19
kaplan-meier estimate (19) 19
recurrence (19) 19
survival (19) 19
cohort studies (18) 18
acute lymphoblastic-leukemia (17) 17
asparaginase - administration & dosage (17) 17
hemic and lymphatic diseases (17) 17
mutation (17) 17
polymorphism, single nucleotide (17) 17
prognostic-factors (17) 17
survival rate (17) 17
lymphoid neoplasia (16) 16
methotrexate (16) 16
precursor b-cell lymphoblastic leukemia-lymphoma - genetics (16) 16
retrospective studies (16) 16
adolescents (15) 15
follow-up studies (15) 15
lymphatic leukemia (15) 15
precursor cell lymphoblastic leukemia-lymphoma - pathology (15) 15
precursor cell lymphoblastic leukemia-lymphoma - therapy (15) 15
remission induction (15) 15
acute lymphocytic-leukemia (14) 14
antineoplastic combined chemotherapy protocols - administration & dosage (14) 14
gene expression (14) 14
genome-wide association study (14) 14
acute myeloid-leukemia (13) 13
asparaginase (13) 13
genetic predisposition to disease (13) 13
genotype (13) 13
hunger (13) 13
relapse (13) 13
trial (13) 13
analysis (12) 12
childrens oncology group (12) 12
classification (12) 12
genomes (12) 12
ikaros transcription factor - genetics (12) 12
antineoplastic agents - administration & dosage (11) 11
asparaginase - adverse effects (11) 11
clinical trials (11) 11
dexamethasone - administration & dosage (11) 11
genetics & heredity (11) 11
pedi2 (11) 11
precursor b-cell lymphoblastic leukemia-lymphoma - drug therapy (11) 11
100 (10) 10
antineoplastic agents - therapeutic use (10) 10
bone neoplasms - drug therapy (10) 10
mutations (10) 10
oncogene proteins, fusion - genetics (10) 10
pharmacokinetics (10) 10
philadelphia chromosome (10) 10
precursor b-cell lymphoblastic leukemia-lymphoma - mortality (10) 10
precursor cell lymphoblastic leukemia-lymphoma - diagnosis (10) 10
prospective studies (10) 10
stem-cell transplantation (10) 10
toxicity (10) 10
age factors (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2012, Volume 30, Issue 14, pp. 1663 - 1669
Journal Article
Nature Genetics, ISSN 1061-4036, 12/2013, Volume 45, Issue 12, pp. 1494 - 1498
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 9, pp. 906 - 915
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1659 - 1666
Journal Article
Nature Genetics, ISSN 1061-4036, 08/2017, Volume 49, Issue 8, pp. 1211 - 1218
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 11, pp. 1005 - 1015
About 25% of young adults with ALL have Ph-like genotypes, which are associated with poor outcomes with conventional treatment. In this gene-expression study,... 
MEDICINE, GENERAL & INTERNAL | MODELS | B-CELL PRECURSOR | INHIBITOR THERAPY | IMATINIB | PEDIATRIC ACUTE LEUKEMIAS | GENE FUSION | EXPRESSION | ETV6-NTRK3 FUSION TRANSCRIPTS | CRLF2 | DELETION | Oligonucleotide Array Sequence Analysis | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Humans | Child, Preschool | Infant | Male | Young Adult | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Heterografts | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Adult | Female | DNA, Neoplasm - analysis | Receptors, Cytokine - metabolism | Child | Philadelphia Chromosome | Receptors, Cytokine - genetics | Signal Transduction - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Animals | Protein Kinase Inhibitors - therapeutic use | Adolescent | Survival Analysis | Mice | Polymorphism, Single Nucleotide | Genome, Human | Protein-Tyrosine Kinases - antagonists & inhibitors | Development and progression | Care and treatment | Genetic aspects | Research | Lymphocytic leukemia | Tyrosine metabolism | Cell proliferation | Adolescence | Tyk2 protein | Leukemia | Genes | Clinical trials | Oncology | Genomes | Kinases | Cell activation | Janus kinase 2 | Xenografts | Teenagers | Children | Protein-tyrosine kinase | Age | Tyrosine | Young adults | Genomic analysis | Acute lymphatic leukemia | Stat5 protein | Lymphatic leukemia | Gene expression | Philadelphia chromosome | Interleukin 7 receptors | Thymic stromal lymphopoietin | Lymphocytes B | Cell lines | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2009, Volume 27, Issue 31, pp. 5175 - 5181
Journal Article
Nature, ISSN 0028-0836, 01/2012, Volume 481, Issue 7380, pp. 157 - 163
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2009, Volume 360, Issue 5, pp. 470 - 480
Journal Article
Nature Genetics, ISSN 1061-4036, 09/2009, Volume 41, Issue 9, pp. 1001 - 1005
Using the Affymetrix 500K Mapping array and publicly available genotypes, we identified 18 SNPs whose allele frequency differed significantly(P < 1 × 10−5)... 
IKAROS GENE ENCODES | POLYMORPHISMS | WIDE ANALYSIS | IN-VIVO | GENETICS & HEREDITY | DNA-BINDING PROTEINS | METHYLENETETRAHYDROFOLATE REDUCTASE MTHFR | NATIONAL-INSTITUTE | BIPOLAR DISORDER | MINIMAL RESIDUAL DISEASE | EXPRESSION | Haplotypes | Humans | Child, Preschool | Methotrexate - therapeutic use | Case-Control Studies | Genetic Variation | Ikaros Transcription Factor - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Germ-Line Mutation | Gene Expression Regulation, Neoplastic - drug effects | Odds Ratio | Child | Antimetabolites, Antineoplastic - metabolism | European Continental Ancestry Group - genetics | Genetic Predisposition to Disease | Genome-Wide Association Study | Polyglutamic Acid - metabolism | Reproducibility of Results | Methotrexate - metabolism | Gene Frequency | Risk Factors | Trans-Activators | Probability | Gene Dosage | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Germ Cells | Chromosomes, Human, Pair 7 | Linkage Disequilibrium | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Antimetabolites, Antineoplastic - therapeutic use | Dopa Decarboxylase - genetics | Oncogene Proteins, Fusion - genetics | Alleles | Polymorphism, Single Nucleotide | Chromosomes, Human, Pair 10 | Precursor Cell Lymphoblastic Leukemia-Lymphoma - classification | Cohort Studies | Genetic aspects | Single nucleotide polymorphisms | Research | Children | Acute lymphocytic leukemia | Health aspects | Risk factors | Studies | Chemotherapy | Research methodology | Leukemia | Colleges & universities | Cell cycle | Genetics | Bipolar disorder | Gene expression | Drug therapy | Cancer | Index Medicus
Journal Article